Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Lee

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Clinical Medicine & Research|November 24, 2005
Warfarin initiation and the potential role of genomic-guided dosingCraig R Lee
Personalized Medicine|May 20, 2018
Research Highlights: Highlights from the latest articles in personalized cardiovascular medicineBrian P Simmons, Craig R Lee
Future Cardiology|August 7, 2019
A case for genotype-guided de-escalation of antiplatelet therapy after percutaneous coronary angioplastyLarisa H Cavallari, Craig R Lee
JAMA Cardiology|October 31, 2019
Logistical Challenges Associated With Implementing Precision MedicineGeorge A Stouffer, Craig R Lee
The New England Journal of Medicine|November 26, 2015
Resolvin Infectious Inflammation by Targeting the Host ResponseCraig R Lee, Darryl C Zeldin
Personalized Medicine|May 13, 2018
Highlights from recent advances in antiplatelet pharmacogenomicsJohn Andrew Lee, Craig R Lee
Pharmacogenomics|November 6, 2007
Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease riskKatherine N Theken, Craig R Lee
Environmental Health Perspectives|August 21, 2003
The reality of pharmacogenomics: optimizing therapeutic decision makingCraig R Lee, Darryl C Zeldin
Circulation. Genomic and Precision Medicine|July 11, 2018
Response by Lee and Stouffer to Letter Regarding Article, "Clinical Outcomes and Sustainability of Using <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention"Craig R Lee, George A Stouffer
The Annals of Pharmacotherapy|November 19, 2009
The impact of ezetimibe on endothelial function and other markers of cardiovascular riskAlmasa Bass, Alan L Hinderliter, Craig R Lee
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Clinical Medicine & Research|November 24, 2005
Warfarin initiation and the potential role of genomic-guided dosingCraig R Lee
Personalized Medicine|May 20, 2018
Research Highlights: Highlights from the latest articles in personalized cardiovascular medicineBrian P Simmons, Craig R Lee
Future Cardiology|August 7, 2019
A case for genotype-guided de-escalation of antiplatelet therapy after percutaneous coronary angioplastyLarisa H Cavallari, Craig R Lee
JAMA Cardiology|October 31, 2019
Logistical Challenges Associated With Implementing Precision MedicineGeorge A Stouffer, Craig R Lee
The New England Journal of Medicine|November 26, 2015
Resolvin Infectious Inflammation by Targeting the Host ResponseCraig R Lee, Darryl C Zeldin
Personalized Medicine|May 13, 2018
Highlights from recent advances in antiplatelet pharmacogenomicsJohn Andrew Lee, Craig R Lee
Pharmacogenomics|November 6, 2007
Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease riskKatherine N Theken, Craig R Lee
Environmental Health Perspectives|August 21, 2003
The reality of pharmacogenomics: optimizing therapeutic decision makingCraig R Lee, Darryl C Zeldin
Circulation. Genomic and Precision Medicine|July 11, 2018
Response by Lee and Stouffer to Letter Regarding Article, "Clinical Outcomes and Sustainability of Using <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention"Craig R Lee, George A Stouffer
The Annals of Pharmacotherapy|November 19, 2009
The impact of ezetimibe on endothelial function and other markers of cardiovascular riskAlmasa Bass, Alan L Hinderliter, Craig R Lee
Pageof 13